(NYSE: ALC) Alcon's forecast annual revenue growth rate of 6.4% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.92%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.98%.
Alcon's revenue in 2026 is $10,634,000,000.On average, 26 Wall Street analysts forecast ALC's revenue for 2026 to be $5,478,821,800,000, with the lowest ALC revenue forecast at $5,169,132,300,000, and the highest ALC revenue forecast at $5,855,326,200,000. On average, 23 Wall Street analysts forecast ALC's revenue for 2027 to be $5,830,941,200,000, with the lowest ALC revenue forecast at $5,455,899,900,000, and the highest ALC revenue forecast at $6,207,933,300,000.
In 2028, ALC is forecast to generate $6,273,285,100,000 in revenue, with the lowest revenue forecast at $5,874,834,200,000 and the highest revenue forecast at $7,392,068,900,000.